NACF Conference Could Create Catalyst for Vertex (VRTX) - Analyst
Go back to NACF Conference Could Create Catalyst for Vertex (VRTX) - Analyst| Bristol-Myers Squibb (NYSE: BMY) | Delayed: 55.57 -1.7 (2.97%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $57.27 | 52 Week High | $77.12 | |||
| Open | $57.16 | 52 Week Low | $49.03 | |||
| Day High | $57.42 | P/E | 36.08 | |||
| Day Low | $55.53 | EPS | $1.54 | |||
| Volume | 11,919,681 | |||||
| Gilead Sciences (NASDAQ: GILD) | Delayed: 128.10 -1.06 (0.82%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $129.16 | 52 Week High | $108.63 | |||
| Open | $130.07 | 52 Week Low | $71.39 | |||
| Day High | $130.80 | P/E | 70.77 | |||
| Day Low | $127.13 | EPS | $1.81 | |||
| Volume | 7,808,859 | |||||
| Vertex Pharmaceuticals Inc (NASDAQ: VRTX) | Delayed: 442.96 -3.87 (0.87%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $446.83 | 52 Week High | $134.71 | |||
| Open | $443.17 | 52 Week Low | $73.31 | |||
| Day High | $448.69 | P/E | N/A | |||
| Day Low | $441.72 | EPS | $-1.98 | |||
| Volume | 1,149,271 | |||||
